berberine has been researched along with Leukemia, Myeloid, Acute in 5 studies
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Berberine (BBR) is the main bioactive ingredient extracted from traditional Chinese medicines, such as Coptis and Scutellaria, which protect liver function and relieve liver steatosis." | 4.31 | Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease. ( Cheng, M; Huang, C; Jia, PC; Li, HD; Li, J; Li, JJ; Liu, JY; Lv, XW; Niu, XN; Xu, JJ; Zhu, L, 2023) |
| " However, the poor water solubility and low bioavailability observed with oral BBR administration has limited its clinical use." | 1.48 | Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine. ( Gao, L; Gong, L; Li, J; Qiu, H; Shen, R; Shi, Z; Sun, H; Tian, Z; Yang, L; Zhang, G, 2018) |
| "Berberine plays a prominent role on the control of tumor cell invasion and migration." | 1.35 | Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells. ( Du, W; Fan, L; Fu, B; Guo, L; Huang, S; Jie, S; Li, H; Liu, W; Wang, X; Zhu, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, L | 1 |
| Xu, JJ | 1 |
| Li, HD | 1 |
| Li, JJ | 1 |
| Cheng, M | 1 |
| Niu, XN | 1 |
| Jia, PC | 1 |
| Liu, JY | 1 |
| Huang, C | 1 |
| Lv, XW | 1 |
| Li, J | 2 |
| Huang, Z | 1 |
| Shen, Y | 1 |
| Liu, W | 2 |
| Yang, Y | 1 |
| Guo, L | 2 |
| Yan, Q | 1 |
| Wei, C | 1 |
| Guo, Q | 1 |
| Fan, X | 1 |
| Ma, W | 1 |
| Huang, G | 1 |
| Yin, Z | 1 |
| Wang, X | 2 |
| Wen, Z | 1 |
| Su, R | 1 |
| Li, C | 1 |
| Liu, Y | 1 |
| Yang, J | 1 |
| Hu, H | 1 |
| Nie, H | 1 |
| Zeng, X | 1 |
| Fei, J | 1 |
| Yang, L | 1 |
| Shen, R | 1 |
| Gong, L | 1 |
| Tian, Z | 1 |
| Qiu, H | 1 |
| Shi, Z | 1 |
| Gao, L | 1 |
| Sun, H | 1 |
| Zhang, G | 1 |
| Li, H | 1 |
| Jie, S | 1 |
| Zhu, J | 1 |
| Du, W | 1 |
| Fan, L | 1 |
| Fu, B | 1 |
| Huang, S | 1 |
5 other studies available for berberine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Ethanol; Fatty Liver; Leukemia, Myeloid, Acute; L | 2023 |
Berberine targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia with IDH1 mutation.
Topics: Berberine; Electron Transport; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mitochond | 2023 |
System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
Topics: Animals; Berberine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; | 2023 |
Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
Topics: Absorption, Physiological; Administration, Oral; Animals; Antineoplastic Agents; Berberine; Cell Dea | 2018 |
Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells.
Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Berberine; Bone Marrow Cells; Cell Movement; Chemo | 2008 |